Skip to content

MCRB

Seres Therapeutics, Inc.

NASDAQ · USHealthcareBiotechnology
$5.11-4.13%

Price as of Jul 20, 2026

MCRB analysis

Seres Therapeutics, Inc. stock analysis

Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.

Analysis for MCRB is not published yet

Browse the public research library while company-specific analysis is being prepared. Explore research